1. Introduction {#sec1}
===============

Pyrethroid pesticides are widely used throughout the world both in agriculture and in household applications ([@bib12]). They act on axons in the peripheral and central nervous systems of insects, causing prolonged opening of sodium channels ([@bib5]), but they have relatively low acute toxicity in mammals, and are not persistent in the environment ([@bib48]). However, it has been reported that pyrethroids induce some adverse effects in mammals. In rodents, pyrethroids caused neurotoxicity upon acute as well as chronic exposure ([@bib47]). Deltamethrin is known to increase oxidative stress, resulting in wide toxic effects including hepatotoxicity and nephrotoxicity, and several protective substances against the toxicity have been found in rats ([@bib2], [@bib3]; [@bib4]). The widespread use of pyrethroids has resulted in their frequent detection in humans, and their metabolites are utilized as biomarkers ([@bib20]). In addition, several pyrethroids have shown estrogenic and anti-androgenic activities in *in vitro* studies ([@bib7]; [@bib13]; [@bib28]; [@bib16]). [@bib53] reported that *cis-/trans-*permethrin exhibit estrogenic and anti-androgenic activities, which are modified by metabolism.

*Trans-*permethrin is rapidly hydrolyzed to 3-phenoxybenzyl alcohol (PBAlc) by carboxylesterase ([@bib6]; [@bib19]; [@bib45]), and is oxidized to 3-phenoxybenzaldehyde (PBAld) and 3-phenoxybenzoic acid (PBAcid) by cytochrome P450 (CYP) ([@bib40]). Alcohol dehydrogenase and aldehyde dehydrogenase also contribute to oxidation to PBAlc and PBAld, respectively ([@bib14]; [@bib21]). On the other hand, *cis-*permethrin is resistant to hydrolysis ([@bib41]; [@bib40]), but is metabolized to hydroxylated derivatives by CYP ([@bib53]). Phenothrin is also hydrolyzed to PBAlc ([@bib23]). Estrogenic activity of *trans-*permethrin has been reported, and the activity was maintained after metabolism, because the hydrolyzed metabolites have similar estrogenic activities to the parent compound. In contrast, the activity of *cis-*permethrin was markedly enhanced by metabolism, because *cis-*permethrin is mainly hydroxylated to 4′-OH *cis-*permethrin, which shows higher estrogenic activity than the parent compound ([@bib53]). Thus, differences of metabolism between *trans-* and *cis-*permethrin could influence their endocrine-disrupting activities.

Pregnane X receptor (PXR), constitutive androstane receptor (CAR) and peroxisome proliferator-activated receptor α (PPARα) are members of the nuclear receptor superfamily. The induction of drug-metabolizing enzymes and transporters is predominantly regulated by these receptors ([@bib43]). PXR and CAR have overlapping target CYP genes. Induction of CYP2B, CYP2C and CYP3A gene expression is mediated by both receptors ([@bib37]). In contrast, PPARα primarily induces the expression of CYP4A ([@bib32]). These receptors regulate not only CYP but also phase II enzymes such as uridine 5′-diphospho-glucuronosyltransferases (UGTs), glutathione *S*-transferases and sulfotransferases (SULTs) ([@bib24]; [@bib27]; [@bib11]). In addition, PXR and CAR may contribute to the regulation of carboxylesterase ([@bib49]). Because pyrethroids are metabolized by carboxylesterases and CYPs, the activation of PXR, CAR and PPARα could increase the extent of their metabolism.

Activation or inactivation of these receptors can also cause endocrine disruption indirectly, since endogenous hormones are metabolized by various enzymes, including CYPs, UGTs and SULTs. Thus, induction of these enzymes by PXR, CAR and PPARα promotes the inactivation of hormones. For example, CAR agonists reduce thyroid hormone levels by inducing UGTs ([@bib46]). In addition, phthalates, which are PPARα agonists, reduce serum estradiol levels by inhibiting the gene expression of aromatase, which catalyzes the conversion of testosterone to estrogen ([@bib36]). Activation of mouse and human PXR by pyrethroids has been reported ([@bib30]; [@bib1]), but the activation of CAR and PPARα by pesticides including pyrethroids has been little studied.

The effects of metabolic modification upon estrogen receptor and androgen receptor agonistic activities have been investigated. Indeed, various proestrogens, which are estrogenic only after metabolism by the microsomal CYP system, such as methoxychlor, trans-stilbene, diphenyl, 2,2-diphenylpropane, benzo\[*a*\]pyrene, 2-nitrofluorene and benzophenone-3, have been identified in *in vitro* estrogen screening tests ([@bib26]; [@bib57]). Thus, it is important to consider the effects of metabolic modification. However, the contributions of metabolic activation and inactivation to the PXR, CAR and PPARα agonistic activities of pyrethroids have not been investigated.

Pyrethroid pesticides can be mainly divided into two groups based on their chemical structures. Type I pyrethroids, such as *cis-/trans*-permethrin and allethrin, lack a cyano group, whereas type II pyrethroids, such as cypermethrin and deltamethrin, contain a cyano group. In the present study, we examined the ability of eight pyrethroids, i.e., *cis-/trans-*permethrin, allethrin, bioresmethrin and phenothrin (type I), and cypermethrin, deltamethrin and fenvalerate (type II) ([Fig. 1](#fig1){ref-type="fig"}), to activate rat PXR, CAR and PPARα. Furthermore, we examined the effects of metabolism by the rat liver microsomal system on their activities.Fig. 1Structures of pyrethroids used in this study. Type I: pyrethroids not containing a cyano group. Type II: pyrethroids containing a cyano group.Fig. 1

2. Materials and methods {#sec2}
========================

2.1. Chemicals {#sec2.1}
--------------

The structure, source and purity of each of the eight pyrethroids and the authentic samples of their metabolites tested in the present study are shown in [Fig. 1](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}. 5-Pregnen-3β-ol-20-one-16α-carbonitrile (PCN; \>97% pure) and artemisinin (\>97% pure) were purchased from Sigma-Aldrich (St. Louis, MO, USA), and Tokyo Chemical Industry Co. Ltd. (TCI; Tokyo, Japan), respectively. Bezafibrate (BZF; \>99.3% pure) and dimethyl sulfoxide (DMSO; \>99.5% pure) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).Table 1Source and purity of pyrethroids and the metabolites used in this study.Table 1CompoundSourcePurity (%)allethrinWako\>98.0 (for Pesticide Residue Analysis)bioresmethrinWako95.0 (for Pesticide Residue Analysis)cypermethrinWako\>96.0 (for Pesticide Residue Analysis)deltamethrinWako99.0 (for Pesticide Residue Analysis)fenvalerateWako99.0 (for Pesticide Residue Analysis)*cis-*permethrinWako98.0*trans-*permethrinWako98.0phenothrinEhrenstorfer97.53-phenoxybenzyl alcohol (PBAlc)Wako98.03-phenoxybenzyl aldehyde (PBAld)Wako97.03-phenoxybenzoic acid (PBAcid)Wako98.0[^1][^2]

2.2. Cells and plasmids {#sec2.2}
-----------------------

COS-1 cells derived from African green monkey kidney were obtained from RIKEN BioResource Center (Ibaraki, Japan). Dulbecco\'s modified Eagle\'s medium (high glucose) with [l]{.smallcaps}-glutamine, phenol red and sodium pyruvate (D-MEM) was purchased from Wako Pure Chemical Industries, Ltd. Fetal bovine serum (FBS) was purchased from Sigma-Aldrich. Antibiotic-Antimycotic (Anti-Anti), MEM non-essential amino acids (MEM NEAA) and 0.5% trypsin-ethylenediaminetetraacetic acid (EDTA) disodium salt solution were obtained from Life Technologies, Inc. (Carlsbad, CA, USA).

Cells were routinely cultured in D-MEM supplemented with 10% FBS, 1% Anti-Anti and 1% MEM NEAA at 37 °C, in an atmosphere of 5% CO~2~/95% air under saturating humidity, as described in our previous report ([@bib17]). Plasmids used in this study were as described previously ([@bib17]).

2.3. Reporter gene assay {#sec2.3}
------------------------

COS-1 cells were plated in 96-well plates (Thermo Fisher Scientific, Waltham, MA, USA) at 1×10^4^ cells/well in D-MEM supplemented with 10% FBS, 1% Anti-Anti and 1% MEM NEAA. The cells were transfected with 6.25 ng/well of the expression plasmid, 100 ng/well of the reporter plasmid and 10 ng/well of the internal control plasmid using the jetPEI transfection reagent (PolyPlus Transfection, Illkirch, France) at the same time. After 24 h (assay for rat PXR and rat PPARα) or 12 h (assay for rat CAR), the cells were exposed to various concentrations of test compounds or 0.1% DMSO (vehicle control) in D-MEM supplemented with 1% Anti-Anti and 1% MEM NEAA (without FBS). After 24 h incubation with chemicals, cells were harvested with 25 μl of passive lysis buffer (Promega). Luciferase assays were performed using a Dual Luciferase Assay Kit (Promega), and luminescence was measured with the luminometer Luminoskan Ascent (Thermo Fisher Scientific). Firefly luciferase activity was normalized to *Renilla* luciferase activity of phRL-tk. Results are expressed as means ± standard deviation (SD) from at least three independent experiments performed in duplicate. Details were described in our previous report ([@bib17]).

DMSO was used as a vehicle, and all test compounds used were dissolved in DMSO at a concentration of 30 mM. The final DMSO concentration in the culture medium did not exceed 0.1%, and this concentration did not affect cell yields. All compounds were diluted to the predetermined concentrations in appropriate medium immediately before use.

Relative activities toward rat PXR, CAR and PPARα are presented in terms of 20% relative effective concentration (REC~20~) for agonistic activities and 20% relative inverse agonistic active concentration (RIC~20~) for inverse agonistic activity. REC~20~ means the concentration of test compounds showing 20% of the agonistic activity of the positive control (1 μM PCN for rat PXR, 30 μM artemisinin for rat CAR and 30 μM BZF for rat PPARα), while RIC~20~ means the concentration of test compound showing 80% of the activity of the vehicle control.

2.4. Animals for the preparation of liver microsomes {#sec2.4}
----------------------------------------------------

Male Sprague Dawley rats (Slc:SD, 210--230 g, Japan SLC, Shizuoka, Japan), which are commonly used in studies on drug-metabolism and chemical toxicity, were used to prepare inducer-treated liver microsomes. The animals were housed at 22 °C and a relative humidity of 55% with a 12-hr light/dark cycle, with free access to tap water and standard pellet diet MM-3 (Funabashi Farm, Funabashi, Japan). In this experiment, to prepare CYP-enriched liver microsomes, which efficiently metabolize chemical, as reported previously ([@bib57]; [@bib17]), rats were co-treated with typical CYP inducers, phenobarbital (PB, which induces mainly CYP2B and CYP3A) and 3-methylcholanthrene (MC, which induces CYP1A) once per day for 3 consecutive days at 80 mg/kg (i.p.) and 25 mg/kg (p.o.), respectively. These experiments were approved by "Animal Experiment Ethics Committee" of Nihon Pharmaceutical University, and were conducted in accordance with the "Guide for the Care and Use of Laboratory Animals" of Nihon Pharmaceutical University.

2.5. Preparation of liver microsomes {#sec2.5}
------------------------------------

Rat liver was homogenized with four volumes of 1.15% potassium chloride, and the homogenate was centrifuged at 9,000 xg for 20 min. The supernatant was further centrifuged at 105,000 xg for 60 min to obtain cytosol and microsomes. These microsomes were washed by resuspension in two volumes of 1.15% potassium chloride solution at 105,000 xg for 60 min. The microsomal pellets were resuspended in the solution to make 1 ml equivalent to 1 g of liver.

2.6. Metabolism by rat liver microsomes {#sec2.6}
---------------------------------------

The incubation mixture consisted of 1 μmol of pyrethroid, an NADPH-generating system (1 μmol of NADPH, 5 μmol of [d]{.smallcaps}-glucose-6-phosphate disodium salt and 1 unit of glucose-6-phosphate dehydrogenase), which can sustainably regenerate NADPH, and rat liver microsomes of PB- and MC-treated rats (60 mg protein) in a final volume of 20 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). Rat microsomes boiled for 10 min at 90 °C were used as the control. The incubation was continued for 30 min at 37 °C. After incubation, the mixture was extracted with 25 ml of ethyl acetate. This metabolism condition was reported previously ([@bib53]). The extract was evaporated to dryness and the residue, which contains both unchanged pyrethroid and formed metabolites, was dissolved in DMSO at a concentration of 30 mM, determined as the initial concentration of unchanged form. This solution was diluted to predetermined concentrations as required. Aliquots were used to examine the effect of metabolism on the receptor agonistic activities.

2.7. Statistical analysis {#sec2.7}
-------------------------

Data analysis was conducted using Mini StatMate software (ATMS, Tokyo, Japan). Dunnett\'s method was used to evaluate the significance of differences in transcriptional levels between the experiment groups and the control group (0.1% DMSO alone). Student\'s t-test was used to evaluate the significance of differences in transcriptional levels between a test group (extract of incubation mixture with native microsomes) and the control group (extract of incubation mixture with boiled microsomes). Data are presented as means ± SD.

3. Results {#sec3}
==========

3.1. Agonistic activities of pyrethroid pesticides toward PXR, and the effects of metabolism {#sec3.1}
--------------------------------------------------------------------------------------------

The ability of the eight pyrethroids to activate rat nuclear receptor PXR by reporter gene assay was examined. PCN, a positive control for rat PXR, enhanced luciferase activity 3.2-fold compared to DMSO-treated cells (control) at the concentration of 1 μM ([Fig. 2](#fig2){ref-type="fig"}A). All the pyrethroids used in this study showed PXR agonistic activity. The activities of *cis-/trans-*permethrin, allethrin, cypermethrin, deltamethrin and fenvalerate were enhanced about 2-fold at the concentration of 1 μM or lower, compared with the control and further increased to about 3-fold in the concentration range of 1--30 μM. However, bioresmethrin and phenothrin showed relatively weak activities. PBAlc, the hydrolysis product of *cis-/trans*-permethrin and phenothrin, showed weak PXR agonistic activity at the concentration of 30 μM, whereas the oxidized products, PBAld and PBAcid, were inactive ([Fig. 2](#fig2){ref-type="fig"}A). The effect of metabolism on the PXR activities of pyrethroids was examined using the mixed function oxidase system of microsomes from liver of PB- and MC-co-treated rats in the presence of NADPH. The PXR activities of all eight pyrethroids were decreased upon incubation with the microsomes ([Fig. 2](#fig2){ref-type="fig"}B). Among these pyrethroids, PXR activation by fenvalerate was markedly decreased at 3--30 μM. The activities of *cis-/trans-*permethrin, phenothrin and deltamethrin at high concentrations were also decreased, e.g. to the control level in the case of phenothrin ([Fig. 2](#fig2){ref-type="fig"}B).Fig. 2Agonistic activities of pyrethroids toward PXR (A), and the effects of metabolism (B). (A); PXR activation of pyrethroids was expressed as n-fold induction versus the vehicle control. Each value represents the mean ± SD of 3 individual experiments. \**p* \< 0.05 indicates a significant difference from the vehicle control (Dunnett\'s test). (B); Pyrethroids were incubated with native or boiled liver microsomes in the presence of NADPH, and extracts of the incubation mixtures were assayed. Each value represents the mean ± SD of 3 individual experiments. \**p* \< 0.05 indicates a significant difference from the control experiment using boiled microsomes (Student\'s t-test). Other details are described in Materials and Methods. PCN: 5-pregnen-3β-ol-20-one-16α-carbonitrile.Fig. 2

3.2. Activities of pyrethroid pesticides toward CAR, and the effects of metabolism {#sec3.2}
----------------------------------------------------------------------------------

In rat CAR activation assay, artemisinin, a positive control for rat CAR, enhanced luciferase activity 1.9-fold at the concentration of 30 μM ([Fig. 3](#fig3){ref-type="fig"}A). Among the pyrethroids tested, *cis-*permethrin and *trans*-permethrin showed CAR agonistic activity at higher concentrations. In contrast, bioresmethrin, phenothrin, deltamethrin and fenvalerate showed CAR inverse agonistic activity, i.e., they suppressed the constitutive activity of the control. In particular, fenvalerate decreased the activity in a dose-dependent manner in the concentration range of 1--30 μM. On the other hand, PBAlc, PBAld and PBAcid did not show CAR agonistic or inverse agonistic activity ([Fig. 3](#fig3){ref-type="fig"}A). Next, we examined the effect of fenvalerate on CAR activation induced by artemisinin (10 μM). As shown in [Fig. 3](#fig3){ref-type="fig"}B, fenvalerate significantly inhibited CAR activation by artemisinin in the range of 0.1--30 μM. However, after incubation of fenvalerate with liver microsomes in the range of 3--10 μM, its CAR inverse agonistic activity tended to decrease ([Fig. 3](#fig3){ref-type="fig"}C). Based on the *Renilla* luciferase activity, a cytotoxic effect was found at the concentration of 30 μM after metabolism.Fig. 3The activities of pyrethroids toward CAR (A), the activity of fenvalerate in the presence of artemisinin (10 μM) (B), and the effect of metabolism (C). (A); CAR activation of pyrethroids was expressed as n-fold induction versus the vehicle control. Each value represents the mean ± SD of 3 individual experiments. \**p* \< 0.05 indicates significant differences from the vehicle control (Dunnett\'s test). (B); the activity was expressed as n-fold induction versus the activity of artemisinin (10 μM). \**p* \< 0.05 indicates a significant difference from the control experiment in the presence of artemisinin (10 μM) (Student\'s t-test). (C); the activity was expressed as n-fold induction versus the vehicle control using COS-1 cells. Each bar represents the mean ± SD of 3 individual experiments. There is no significant difference between the boiled microsome group and the experimental group (Student\'s t-test).Fig. 3

3.3. Agonistic activities of *cis-/trans-*permethrin toward PPARα, and the effects of metabolism {#sec3.3}
------------------------------------------------------------------------------------------------

The activities of pyrethroids, as well as the hydrolysis product PBAlc and the oxidized products PBAld and PBAcid of *cis-/trans-*permethrin, toward rat PPARα were examined. BZF, a positive control, enhanced luciferase activity 2.4-fold at the concentration of 30 μM ([Fig. 4](#fig4){ref-type="fig"}). None of the eight pyrethroids exhibited PPARα agonistic activity (data not shown). However, PBAcid showed dose-dependent agonistic activity. PBAld also showed weak activity at 30 μM ([Fig. 4](#fig4){ref-type="fig"}). We could not determine the effects of the metabolism, because the extract obtained after incubation without pyrethroids exhibited PPARα agonistic activity (data not shown).Fig. 4Agonistic activity of *cis-/trans-*permethrin and the metabolites PBAlc, PBAld and PBAcid toward PPARα. PPARα activation of pyrethroids was expressed as n-fold induction versus the vehicle control. Each value represents the mean ± SD of 3 individual experiments. \**p* \< 0.05 indicates a significant difference from the vehicle control (Dunnett\'s test). BZF: bezafibrate, PBAlc: 3-phenoxybenzyl alcohol, PBAld: 3-phenoxybenzaldehyde, PBAcid: 3-phenoxybenzoic acid.Fig. 4

3.4. Relative activities of pyrethroids toward PXR, CAR and PPARα {#sec3.4}
-----------------------------------------------------------------

As the indicator of the relative activities of pyrethroids toward PXR, CAR and PPARα, we used REC~20~ for agonistic activities and RIC~20~ for inverse agonistic activity in this study. The values of REC~20~ for the PXR, CAR and PPARα agonistic activities of pyrethroids and their metabolites and RIC~20~ values for inverse agonistic activity for CAR are summarized in [Table 2](#tbl2){ref-type="table"}. Deltamethrin showed the lowest REC~20~ value for PXR agonistic activity (0.156 μM), followed by *cis-*perimethrin (0.329 μM). The values toward pyrethroids examined in this study are within the range of 0.156--3.89 μM. The order of PXR activation in terms of REC~20~ was deltamethrin \> *cis-*permethrin \> cypermethrin \> fenvalerate \> allethrin \> *trans-*permethrin \> bioresmethrin \> phenothrin. REC~20~ for CAR agonistic activity was evaluated only for *trans-*permethrin (4.19 μM). PBAcid showed a REC~20~ value of 26.8 μM for PPARα agonistic activity, while fenvalerate showed a RIC~20~ value of 0.846 μM for CAR inverse agonistic activity.Table 2Agonistic activities of pyrethroids towards PXR, CAR and PPARɑ.Table 2CompoundAgonistic activity\
REC~20~[a](#tbltbl2fna){ref-type="table-fn"} (±SD, μM)Inverse agonistic activity\
RIC~20~[b](#tbltbl2fnb){ref-type="table-fn"} (±SD, μM)PXRCARPPARɑCARPCN0.0887 ± 0.0118-[d](#tbltbl2fnd){ref-type="table-fn"}-[d](#tbltbl2fnd){ref-type="table-fn"}-[d](#tbltbl2fnd){ref-type="table-fn"}artemisinin-[d](#tbltbl2fnd){ref-type="table-fn"}2.53 ± 4.02-[d](#tbltbl2fnd){ref-type="table-fn"}-[d](#tbltbl2fnd){ref-type="table-fn"}BZF-[d](#tbltbl2fnd){ref-type="table-fn"}-[d](#tbltbl2fnd){ref-type="table-fn"}3.68 ± 0.0944-[d](#tbltbl2fnd){ref-type="table-fn"}deltamethrin0.156 ± 0.0216-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}*cis-*permethrin0.329 ± 0.0472-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}cypermethrin0.468 ± 0.0267-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}fenvalerate0.617 ± 0.138-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}0.846 ± 0.394allethrin0.668 ± 0.129-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}*trans-*permethrin0.674 ± 0.05264.19 ± 3.26-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}bioresmethrin1.92 ± 0.724-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}phenothrin3.89 ± 1.03-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}PBAlc-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}PBAld-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}PBAcid-[c](#tbltbl2fnc){ref-type="table-fn"}-[c](#tbltbl2fnc){ref-type="table-fn"}26.8 ± 21.3-[c](#tbltbl2fnc){ref-type="table-fn"}[^3][^4][^5][^6][^7]

4. Discussion {#sec4}
=============

There are species differences in the ligand-dependent activation of nuclear receptors, such as PXR, CAR, and PPARα. For example, rifampicin activates human PXR, but not mouse and rat PXR, and PCN is an agonist of mouse and rat PXR, but not human PXR. Furthermore, 6-(4-chlorophenyl)imidazo\[2,1-*b*\]\[1,3\]thiazole-5-carbaldehyde *O*-(3,4-dichlorobenzyl)oxime (CITCO) and 1,4-bis\[2-(3,5-dichloropyridyloxy)\]benzene (TCPOBOP) act as agonists of human and mouse CAR, respectively. It has been reported that some pyrethroids possess agonistic activities toward human and/or mouse PXR, CAR and PPARα. For example, [@bib30] observed similar agonistic activities of deltamethrin, fenvalerate, cypermethrin and permethrin (a mixture of *cis-*permethrin and *trans-*permethrin) in human and mouse PXR-mediated transactivation assays using COS-7 cells. In addition, [@bib8] reported that cypermethrin, deltamethrin and fenvalerate were agonists of both human and mouse CAR, although [@bib1] showed that fenvalerate possessed agonistic activity toward human but not mouse CAR. As for PPARα activation, only pyrethrin, among 12 pyrethroid pesticides, activated mouse PPARα ([@bib52]). However, there has been no comprehensive study on the in vitro activation of rat PXR, CAR and PPARα by pyrethroids. In this study, we did not detect rat CAR activation by these pesticides, although *cis-/trans-*permethrin showed weak CAR agonistic activity ([Fig. 3](#fig3){ref-type="fig"}A). Furthermore, fenvalerate showed dose-dependent inverse agonist activity toward rat CAR in this study ([Fig. 3](#fig3){ref-type="fig"}B). On the other hand, [@bib1] reported that fenvalerate showed agonistic activity toward human but not mouse CAR. CITCO and TCPOBOP were reported to be ligands for human and mouse CAR, respectively, but were inactive toward rat CAR ([@bib42]). Thus, there appear to be marked species differences in the response to pyrethroids among human, mouse and rat CAR. These results are in line with those for rat PPARα activation (data not shown).

In this study, the PXR agonistic activity varied markedly among the pyrethroids tested ([Fig. 2](#fig2){ref-type="fig"}A), and some pyrethroids showed CAR activity ([Fig. 3](#fig3){ref-type="fig"}A), while most did not show PPARα activity. However, we could not identify structural requirements for PXR, CAR and PPARα activity. It is considered that PXR shows lower specificity than CAR, because the ligand-binding region in PXR is larger and more flexible than that of CAR ([@bib54]). Actually, the number of chemicals known to activate PXR is much greater than that known to activate CAR ([@bib31]). Also, CAR activity is observed in the absence of ligand activation, as demonstrated in case of phenobarbital ([@bib44]; [@bib39]). Further study of ligand-independent activation of CAR by pyrethroids might be needed.

Metabolic modification of endocrine-disrupting agents can affect their toxicity. Further, hydrolytic metabolites of pyrethroids show greater estrogenic and anti-androgenic activity than the parent compounds ([@bib55]; [@bib38]; [@bib51], [@bib50]; [@bib53]). Carboxylesterase is known to hydrolyze pyrethroids ([@bib45]; [@bib15]). *Cis-/trans-*permethrin is hydrolyzed to PBAlc, and further oxidized to PBAld and PBAcid by CYP and alcohol and aldehyde dehydrogenases ([@bib14]; [@bib40]). In this study, all the pyrethroid pesticides showed agonistic activity against PXR ([Fig. 2](#fig2){ref-type="fig"}A), but the activity was decreased after incubation with rat liver microsomes ([Fig. 2](#fig2){ref-type="fig"}B). It is reported that type I pyrethroid is more easily hydrolyzed than type II by carboxylesterase ([@bib15]), but we observed no systematic difference in the metabolic modification of PXR activity between type I and type II pyrethroids ([Fig. 2](#fig2){ref-type="fig"}B). The PXR activity of phenothrin (type I pyrethroid) was significantly decreased, whereas those of allethrin and bioresmethrin (type I pyrethroid) were slightly decreased by metabolism. Furthermore, the activity of fenvalerate (type II pyrethroid) was significantly decreased by metabolism. The results suggest that other metabolic reactions may contribute to the decrease of PXR activity. Exceptionally, the metabolites of *cis-/trans-*permethrin and phenothrin, PBAld and PBAcid, were more active PPARα agonists than the parent compounds ([Fig. 4](#fig4){ref-type="fig"}). We were unable to investigate the effect of the microsomal metabolism on PPARα activity, because the extract obtained after incubation without pyrethroids exhibited PPARα agonistic activity (data not shown). The enhanced activity may be due to the lipid derived from the microsomes. The metabolic pathways and the effects of *cis-/trans-*permethrin and their metabolites on PXR, CAR and PPARα are summarized in [Fig. 5](#fig5){ref-type="fig"}.Fig. 5Metabolic pathways of *cis-/trans-*permethrin, and summary of the effects of *cis-/trans-*permethrin and their metabolites on PXR, CAR and PPARα. The metabolic pathways are taken from the reports of [@bib14], [@bib21], [@bib40] and [@bib53]. PBAlc: 3-phenoxybenzyl alcohol, PBAld: 3-phenoxybenzaldehyde, PBAcid: 3-phenoxybenzoic acid, ADH: alcohol dehydrogenase, ALDH: aldehyde dehydrogenase.Fig. 5

Exposure of humans to pyrethroids has been reported. The urinary concentration of PBAcid is employed as an indicator of permethrin exposure, and PBAcid has been detected in urine of the general population ([@bib34]; [@bib9]; [@bib33]; [@bib58]). The concentrations of pyrethroids and metabolites used in the present study are higher than the concentrations reported *in vivo*, but humans are exposed to pyrethroid pesticides on a daily basis, so it is important to consider the effect of chronic toxicity.

In conclusion, we found that all the pyrethroids examined showed PXR agonistic activity but were converted to inactive or less active metabolites upon incubation with rat liver microsomes. Fenvalerate showed inverse agonistic activity toward CAR, and this activity decreased after metabolism. PBAcid, a metabolite of *cis-/trans-*permethrin, showed PPARα agonist activity, although pyrethroids themselves were inactive.
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[^1]: Wako: Wako Pure Chemical Industries, Ltd., (Osaka, Japan).

[^2]: Ehrenstorfer: Dr. Ehrenstorfer GmbH (Augsburg, Germany).

[^3]: PCN, 5-Pregnen-3β-ol-20-one-16ɑ-carbonitrile; BZF, bezafibrate; PBAlc, 3-phenoxybenzyl alcohol; PBAld, 3-phenoxybenzaldehyde; PBAcid, 3-phenoxybenzoic acid.

[^4]: 20% relative effective concentration; concentration of test compound showing 20% of the agonistic activity of the positive control (1μM PCN for PXR, 30 μM artemisinin for CAR and 30 μM BZF for PPARα).

[^5]: 20% relative inverse agonistic active concentration; concentration of test compound showing 80% of the activity of the vehicle control.

[^6]: No effect (REC~20~ \> 30 μM).

[^7]: Not tested.
